Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Eli Lilly launched a full TV ad for Mounjaro in March and spent $19.6 million on it.

The ad comes just a few weeks after the once-weekly injection was finally fully re-stocked on shelves after a two-month shortage.

Mounjaro (tirzepatide) is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) agonist, which makes it the first-in-class drug that activates both receptors to help regulate blood sugar and appetite.